Cellectis
CLLS
30 hedge funds and large institutions have $26.1M invested in Cellectis in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 6 closing their positions.
125% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 4
0.05% more ownership
Funds ownership: 13.68% → 13.73% (+0.05%)
12% less funds holding
Funds holding: 34 → 30 (-4)
14% less capital invested
Capital invested by funds: $30.2M → $26.1M (-$4.12M)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
79% less call options, than puts
Call options by funds: $17K | Put options by funds: $82K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Principal Financial Group
Des Moines,
Iowa
|
+$68.9K |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$29.3K |
| 3 |
LPL Financial
San Diego,
California
|
+$25.3K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$22.5K |
| 5 |
Morgan Stanley
New York
|
+$21.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$54.8K |
| 2 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$11.5K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$9.68K |
| 4 |
TVAMP
Tennessee Valley Asset Management Partners
Knoxville,
Tennessee
|
-$7.48K |
| 5 |
Two Sigma Investments
New York
|
-$6.55K |
CLLS Hedge Fund Activity: Q1 2024 in Review
30 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q1 2024, worth a combined $26.1M — down 14% from $30.2M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of CLLS and 3 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 9 added.
The largest buyer was Principal Financial Group, adding an estimated $68.9K. The largest seller was Citadel Advisors, exiting entirely with an estimated $54.8K sold.
- 30 institutional investors held Cellectis (CLLS) as of Q1 2024, down from 34 in Q4 2023.
- Funds reported $26.1M of Cellectis stock for Q1 2024, down 14% quarter-over-quarter.
- 3 funds opened new Cellectis positions in Q1 2024 and 6 closed out, a net change of -3 holders.
- The largest Cellectis buyer in Q1 2024 was Principal Financial Group, an estimated $68.9K added.
- The largest Cellectis seller in Q1 2024 was Citadel Advisors, an estimated $54.8K sold.
Based on aggregated 13F filings for Q1 2024.